Efficacy of omalizumab (Xolair®) in patients with moderate to severe predominately chronic oral steroid dependent asthma in Taiwan: A retrospective, population-based database cohort study
- Hao Cheng Chen
- , Chien Da Huang
- , Erin Chang
- , Han Pin Kuo
Research output: Contribution to journal › Article › peer-review
24
Link opens in a new tab
Citations
(Scopus)